Showing results (2541-2550 of 3,088) with videos related to

Sort By:
Pageof 309
Drug Safety|October 30, 2003
A benefit-risk assessment of sibutramine in the management of obesityEnzo Nisoli, Michele O Carruba
Drug Safety|October 30, 2003
Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription padsJosep Maria Castel, Albert Figueras, Consuelo Pedrós, et al.
Drug Safety|January 15, 2004
Antimalarial drug toxicity: a reviewW Robert J Taylor, Nicholas J White
Drug Safety|October 11, 2019
Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the LiteratureBrahim Azzouz, Aurore Morel, Lukshe Kanagaratnam, et al.
Drug Safety|October 17, 2019
Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European UnionChristina E Hoeve, Reynold D C Francisca, Inge Zomerdijk, et al.
Drug Safety|April 24, 2019
Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development ProgramsSubrata Ghosh, Lianne S Gensler, Zijiang Yang, et al.
Drug Safety|April 12, 2019
Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative ColitisXiao Ding, Qianqian Li, Pan Li, et al.
Drug Safety|September 21, 2018
Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional StudyMartin Schipperus, Georgia Kaiafa, Louise Taylor, et al.
Drug Safety|June 3, 2018
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the LiteratureClotilde Chatre, François Roubille, Hélène Vernhet, et al.
Drug Safety|July 21, 2018
Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilanceVictoria Newbould, Steven Le Meur, Thomas Goedecke, et al.
Pageof 309